Literature DB >> 11193028

The interaction of HSP27 with Daxx identifies a potential regulatory role of HSP27 in Fas-induced apoptosis.

S J Charette1, J Landry.   

Abstract

The heat shock protein HSP27 protects cells against a wide variety of toxic treatments and blocks apoptosis induced by exposures to anticancer drugs and activation of the death receptor Fas. The molecular mechanisms of protection are unknown but appear to be regulated by phosphorylation of HSP27. Two apoptotic pathways can be activated downstream of Fas. The Fas-adaptor FADD mediates a caspase-dependent pathway. Fas also activates a caspase-independent pathway which correlates with Fas-induced translocation of Daxx from the nucleus to the cytoplasm and involves the interaction of Daxx with Fas and Ask1. We found that phosphorylated dimers of HSP27 interact with Daxx, preventing its interaction with Ask1 and Fas and blocking Daxx-mediated apoptosis. Expression of HSP27 also prevents the translocation of Daxx from the nucleus to the cytoplasm which is induced upon expression of Ask1 or stimulation of Fas. The observations reveal a new level of regulation of the Fas pathway. Whereas the FADD axis can be modulated by expression of FLIP, a natural inhibitor of FADD, our results show that HSP27 can accomplish a similar function for the Daxx axis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193028     DOI: 10.1111/j.1749-6632.2000.tb05606.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  38 in total

1.  Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment.

Authors:  Rieko Fujita; Samir Ounzain; Alice Chun Yin Wang; Richard John Heads; Vishwanie Shanie Budhram-Mahadeo
Journal:  Cell Stress Chaperones       Date:  2011-01-29       Impact factor: 3.667

2.  Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.

Authors:  Martin H Pedersen; Brian L Hood; Hans Christian Beck; Thomas P Conrads; Henrik J Ditzel; Rikke Leth-Larsen
Journal:  Oncoimmunology       Date:  2017-03-16       Impact factor: 8.110

3.  In vivo resolution of oligomers with fluorescence photobleaching recovery histograms.

Authors:  B S Youn; J R Lepock; M J Borrelli; E J Jervis
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

4.  Modification and reorganization of the cytoprotective cellular chaperone Hsp27 during herpes simplex virus type 1 infection.

Authors:  Shomita S Mathew; Megan P Della Selva; April D Burch
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

5.  Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation.

Authors:  Daiju Kitagawa; Hiroaki Kajiho; Takahiro Negishi; Seiji Ura; Tomomi Watanabe; Teiji Wada; Hidenori Ichijo; Toshiaki Katada; Hiroshi Nishina
Journal:  EMBO J       Date:  2006-06-29       Impact factor: 11.598

6.  Cellular stress responses: cell survival and cell death.

Authors:  Simone Fulda; Adrienne M Gorman; Osamu Hori; Afshin Samali
Journal:  Int J Cell Biol       Date:  2010-02-21

7.  Ultraviolet radiation-induced apoptosis is mediated by Daxx.

Authors:  Shiyong Wu; Heather N Loke; Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

8.  HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis.

Authors:  Chi Zhang; Shunlin Qu; Xing Wei; Yansheng Feng; Honglin Zhu; Jia Deng; Kangkai Wang; Ke Liu; Meidong Liu; Huali Zhang; Xianzhong Xiao
Journal:  Cell Stress Chaperones       Date:  2015-10-29       Impact factor: 3.667

9.  Daxx silencing sensitizes cells to multiple apoptotic pathways.

Authors:  Liuh-Yow Chen; J Don Chen
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 10.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.